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Objective: There is evidence that reactive stroma in different cancers may regulate tumor 
progression. The aim of this study is to establish any possible relation of reactive stroma 
grading on needle prostatic biopsies to biochemical recurrence.
Materials and Methods: The study group comprised 266 biopsies from consecutive pa-
tients submitted to radical prostatectomy. Reactive stroma was defined as stroma sur-
rounding neoplastic tissue and graded as 0 (absent), 1 (slight), 2 (moderate), and 3 (inten-
se) according to tumor stroma area relative to total tumor area.
Results: From the total of 266 needle prostatic biopsies, 143 (53.8%), 55 (20.7%), 54 
(20.3%), and 14 (5.3%) showed grades 0, 1, 2, and 3, respectively. Increasing reactive 
stroma grade was significantly associated with clinical stage T2, higher preoperative PSA, 
higher biopsy and radical prostatectomy Gleason score, more extensive tumors in radical 
prostatectomy, and pathologic stage > T2. Only grade 3 was significantly associated with 
time and risk to biochemical recurrence. On multivariate analysis only preoperative PSA 
and 2 methods of biopsy tumor extent evaluation were independent predictors.
Conclusion: Increasing reactive stroma grade on biopsies is significantly associated with 
several clinicopathologic adverse findings, however, only grade 3 predicts time and risk 
to biochemical recurrence following radical prostatectomy on univariate but not on mul-
tivariate analysis. We have not been able to show that reactive stroma grade 3 on biopsies 
is an independent predictor of biochemical recurrence beyond that of preoperative PSA 
and other pathologic findings on biopsy.
INTRODUCTION
Several human cancers may induce a stro-
mal reaction (desmoplasia) as a component of car-
cinoma progression. This has been described in 
breast and colon carcinoma (1,2). In cancers with 
stromal reaction, it seems that the response is si-
milar, if not identical, to wound repair response 
(3). Prostate cancer may also be associated with 
wound repair type of reactive stroma composed of 
myofibroblasts and fibroblasts rather than normal 
prostate smooth muscle, which is displaced by the 
reactive stroma (4).
 There is growing evidence that carcino-
genesis is influenced and controlled by cellular 
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interactions derived from a complex relationship 
between stromal, epithelial and extracellular ma-
trix components (4-15). The neoplastic stromal 
environment is different from the stroma of the 
normal tissue and is characterized by modified 
extracellular matrix composition, increased mi-
crovessel density, inflammatory cells and myofi-
broblasts (4,14,15).
A pioneer study by Ayala et al. (16) showed 
that the volume of reactive stroma in surgical spe-
cimens from patients submitted to radical prosta-
tectomy was a significant predictor of biochemical 
recurrence. In a subsequent paper from the same 
group, Yanagisawa et al. (17) showed that intense 
reactive stroma on biopsies was an independent 
predictor of recurrence. The only other study dea-
ling with the prognostic value of reactive stroma 
in prostate carcinoma is Tomas’ et al. (18). Using 
histochemistry and immunohistochemistry in ra-
dical prostatectomies, the authors found that on 
multivariate analysis only vimentin expression in 
reactive stroma was a significant predictor of bio-
chemical recurrence.
Our study aims to establish the possible 
association of prostate cancer reactive stroma 
on needle biopsies and biochemical progression 
following radical prostatectomy.
MATERIALS AND METHODS
This retrospective study comprised 266 nee-
dle prostatic biopsies from 266 consecutive patients 
submitted to retropubic radical prostatectomy. No 
patient in this series received radiotherapy or andro-
gen manipulation before or after surgery. The biopsy 
of the prostate was performed with transrectal ultra-
sound guidance and a spring-loaded 18-gauge ne-
edle instrument. Prostate was imaged in gray-scale 
mode and hypervascularity on color and power Dop-
pler. The mean number and range of the cores obtai-
ned was 9 cores and 2-20 cores, respectively; and the 
mean and range of the length in mm of all cores 53 
mm and 3-150 mm, respectively. All biopsies were 
analyzed by the same senior uropathologist (AB).
Prostatic biopsies
The analysis was done on slides stained with 
hematoxylin and eosin. Reactive stroma was defined 
as stroma surrounding the neoplastic tissue and that 
was not part of the normal preexisting host stroma. 
The scoring system was analyzed according to the 
stroma area relative to total tumor area and was ba-
sed on the system proposed by Ayala et al. (16) and 
Yanagisawa et al. (17). Reactive stroma was graded 
as 0 (absent or up to 5% reactive stroma, Figures 1A 
and B), 1 (slight, 6% to 15% reactive stroma, Figu-
re-1C), 2 (moderate, 16% to 50% reactive stroma, 
Figure-1D), and 3 (intense, > 50% reactive stroma, 
Figure-1E). In biopsies with cores showing different 
grades, the final grading was considered in the core 
with the most extensive carcinoma (index core). Re-
active stroma is easily identified using hematoxylin 
and eosin stain and does not need special stains such 
as Masson’s trichrome.
Grading of reactive stroma was related to 
several clinicopathological variables: age, clinical 
stage, preoperative PSA, biopsy tumor extent using 
several methods of evaluation, radical prostatectomy 
tumor extent, biopsy and radical prostatectomy Gle-
ason score, pathologic stage, and surgical margin sta-
tus. For tumor grading was used the revised Gleason 
system according to the consensus conference of the 
International Society of Urological Pathology (19).
Tumor extent on needle biopsy was evalua-
ted as number of needle biopsy cores with carcinoma 
(NC), number of needle biopsy cores with carcinoma 
divided by the total number of cores (%NC), total 
length of cancer in mm in all cores (mmAC), and 
total length of carcinoma in all cores divided by the 
total length of the cores (%mmAC). Linear extent 
of carcinoma in mm was measured using a single 
micrometer eyepiece with a linear array. In cases of 
discontinuous foci 1mm apart, the tumor was consi-
dered as continuous and the measure included 1mm. 
In discontinuous foci more than 1mm apart, the final 
extent was the sum of the measures.
Surgical specimens
 The surgical specimens were step-sectioned 
at 3 to 5mm intervals and totally embedded in pa-
raffin. A mean of 32 paraffin blocks were pro-
cessed and 6µm sections from each block were 
stained with hematoxylin and eosin. Each trans-
versal section of the prostate was subdivided into 
2 anterolateral and 2 posterolateral quadrants. The 
basal and the apical margins were amputated and 
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the inked specimen surface. Extraprostatic extension 
was diagnosed whenever cancer was seen in adipose 
tissue and, in case of desmoplastic response, whe-
never a protuberance corresponding to extension of 
tumor into periprostatic tissue was observed. Seminal 
vesicle invasion occurred whenever there was invol-
vement of the muscular coat. Tumor extent at radical 
prostatectomy was evaluated by a semiquantitative 
point-count method previously described (20).
 After radical prostatectomy, serum PSA was 
drawn every 3 months during the first year, every 6 
months during the second year, and annually there-
after. No patient had radiotherapy or androgen ma-
nipulation before or after surgery. Total serum PSA 
was measured utilizing previous validated Immulite® 
PSA kit. Biochemical recurrence following surgery 
was considered as PSA ≥ 0.2 ng/mL according to re-
commendation of the American Urological Associa-
tion (21). Patients without evidence of biochemical 
recurrence were censored at last follow-up. Institu-
tional Committee of Ethics approved the study.
Statistical analysis
The data were analyzed using the Qui-square 
test for comparison of proportions, the Kruskal-Wallis 
test for comparison of means, the Kaplan-Meier pro-
duct-limit analysis for the time to biochemical re-
currence using the log-rank test for comparison be-
tween the groups, and a univariate and multivariate 
Cox stepwise logistic regression model to identify 
significant predictors of shorter time to biochemical 
recurrence. The P-values were two-sided at the sig-
nificance level of < 0.05. All statistical analyses were 




Table-1 shows the clinicopathologic charac-
teristics of 266 patients undergoing radical prosta-
tectomy according to biopsy reactive stroma gra-
de. From the total of 266 needle prostatic biopsies, 
143 (53.8%), 55 (20.7%), 54 (20.3%), and 14 (5.3%) 
biopsies showed absent (grade 0), slight (grade 1), 
moderate (grade 2), and intense (grade 3) reactive 
stroma, respectively.
Figure 1 - (A) Grade 0 (absent reactive stroma): Gleason score 
6 adenocarcinoma; (B) Grade 0 (absent reactive stroma): 
Gleason score 7 adenocarcinoma; (C) Grade 1 (slight reactive 
stroma); (D) Grade 2 (moderate reactive stroma); (E) Grade 
3 (intense reactive stroma). Only some few residual smooth 
muscle fibers are seen (arrow) (hematoxylin-eosin, x165).
sectioned parasagittally in a direction perpendicular 
to the initial transverse incision (cone method) obtai-
ning 8 sections from each margin. Positive surgical 
margin was defined as cancer cells in contact with 
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Table 1 - Clinicopathologic characteristics of 266 patients undergoing radical prostatectomy according to biopsy reactive
stroma grade.
Characteristic Grade 0 Grade 1 Grade 2 Grade 3 P value
No. of patients 143 (53.8%) 55 (20.7%) 54(20.3%) 14(5.3%)
Mean (SD; range)
Age, years 64 (6.6;46-76) 62 (6.8;45-73) 63 (7.2;43-73) 65 (4.3;57-72) 0.69
Preoperative PSA (ng/mL) 8.6 (5;0.6-29.7) 9.5 (4.3;2.6-22.1) 11 (7;0.9-29-7) 18.1 (14.7;3.43-50) < 0.01
RP tumor extent
(pos.points)
31.4 (30.9;1-192) 37.4 (30.4;1-147) 46.9 (45.3;5-222) 68.8 (71.2;20-225) 0.02
N (%)
Clinical stage
T1c 81 (58.7) 23 (44.2) 9 (19.6) 2 (16.7) < 0.01
T2 57 (41.3) 29 (55.8) 37 (80.4) 10 (83.3) < 0.01
RP Gleason score
2-6 65 (45.5) 15 (27.3) 10 (19.2) 1 (7.1)
7 73 (51.0) 35 (63.6) 40 (76.9) 11 (78.6)
8-10 5 (3.5) 5 (9.1) 2 (3.8) 2 (14.3)
Biopsy Gleason score
2-6 103 (72.0) 30 (54.5) 32 (59.3) 7 (50.0) 0.02
7 36 (25.2) 21 (38.2) 19 (35.2) 4 (28.6)
8-10 4 (2.8) 4 (7.3) 3 (5.6) 3 (21.4)
Pathologic stage
T2 110 (76.9) 42 (76.4) 35 (64.8) 5 (35.7) 0.01
> T2 (T3a/T3b) 33 (23.1) 13 (23.6) 19 (35.2) 9 (64.3)
Surgical margin status
Negative 86 (60.1) 29 (52.7) 28 (51.9) 5 (35.7) 0.27
Positive 57 (39.9) 26 (47.3) 26 (48.1) 9 (64.3)
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Increasing reactive stroma grade was sig-
nificantly associated with clinical stage T2, higher 
preoperative PSA, higher biopsy and radical pros-
tatectomy Gleason score, more extensive tumors in 
radical prostatectomy, and pathologic stage > T2. 
There was no significant association with age and 
positive surgical margin.
Radical prostatectomies
From the total of 266 men following radical 
prostatectomy, 92 (34.6%) patients had biochemical 
recurrence at a mean, median and range follow-up 
of 19, 8, and 3-111 months; 162 (60.9%) censored 
men remained at risk at a mean, median and range 
follow-up of 59, 57, and 3-141 months, respective-
ly; and, 12 (4.5%) men had no serum PSA data.
At 5 years following radical prostatectomy, 
69%, 59%, 57%, and 39% from a total of 254 pa-
tients with grade 0, 1, 2, and 3 biopsy reactive stro-
ma, respectively, were free of biochemical recur-
rence; 12/266 (4.5%) men had no serum PSA data. 
Only patients with needle biopsies showing grade 3 
reactive stroma were significantly associated with 
shorter time to biochemical recurrence following 
surgery (log-rank, p < 0.01) (Figure-2).
Table-2 shows the Cox proportional hazard 
analysis of several clinicopathologic factors predic-
ting time to biochemical recurrence following ra-
dical prostatectomy. On univariate analysis, preo-
perative PSA, all methods of biopsy tumor extent 
evaluation, and only needle biopsies with grade 3 
reactive stroma were significant predictors of time 
to biochemical recurrence. On multivariate analysis, 
only preoperative PSA and 2 methods of biopsy tu-
mor extent evaluation were independent predictors 
using two models of analysis.
DISCUSSION
We used the system proposed by Ayala et 
al. (16) and Yanagisawa et al. (17) for definition 
and scoring of reactive stroma. Reactive stroma 
was evaluated as stroma surrounding the neoplas-
tic tissue and not part of the normal preexisting 
host stroma. The scoring system was established 
according to the stroma area relative to total tumor 
area. In biopsies with cores showing different gra-
des, the final grading was considered in the core 
with the most extensive carcinoma (index core). 
Reactive stroma is easily identified using hema-
toxylin and eosin stain and does not need special 
stains such as Masson’s trichrome. No patient in 
this series received radiotherapy or androgen ma-
nipulation before or after surgery. This is impor-
tant because both occurrences promote mesanchy-
mal reaction that may interfere with the results.
All patients in our study had only one ne-
edle prostatic biopsy preceding surgery therefore 
there was no selection of biopsies. The mean num-
ber and range of the cores examined was 9 and 
2-20, respectively and the mean and range of the 
length in mm of all cores 53 mm and 3-150 mm, 
respectively. Sampling of the biopsies is important 
for comparison of results.
According to intensity of reactive stro-
ma, the frequency was 143/266 (53.8%), 55/266 
(20.7%), 54 (20.3%), and 14/266 (5.3%) biopsies 
for grades 0, 1, 2, and 3, respectively. The fre-
quency is higher in grade 0 and decreases to grade 
3. On needle biopsies, Yanagisawa et al. (17) found 
a frequency of 1/224 (0.5%), 149/224 (66.5%), 
59/224 (26.3%), and 15/224 (6.7%) biopsies for 
grades 0,1, 2, and 3, respectively. In radical pros-
Figure 2 - Kaplan-Meyer  product-limit analysis comparing 
grades 0, 1, 2, and 3 reactive stroma on needle biopsy from 
254 patients for time to biochemical recurrence following 
radical prostatectomy.
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tatectomies, Ayala et al. (16) found a frequency of 
34/545 (6.2%), 161/545 (29.5%), 306/545 (56.1%) 
, and 44/545 (8%) surgical specimens for grades 0, 
1, 2, and 3, respectively.
The higher frequency of grade 0 (53.8%) 
in our study contrasts with the frequency of 0.5% 
and 6.2% of grade 0 in Yanagisawa’s et al. (17) 
and Ayala’s et al. (16) studies. Considering that 
the method of evaluation of reactive stroma is the 
same, it is difficult to explain this striking diffe-
rence in frequency. Absence of reactive stroma is 
easily discernible as we can see in Figures 1A and 
B. One possible reason may be the additional use 
of trichrome staining to visualize reactive stroma 
in those prior studies. There is also a role of inte-
robserver variability in interpretation of reactive 
stroma particularly when it is absent or lower gra-
de. However, since distinction is more important 
for grade 3, which is relatively easier to identify, 
variation of interpretation in lower grades may 
not be significant.
Increasing reactive stroma grade was sig-
nificantly associated with adverse clinicopatholo-
gic findings. Table-1 clearly shows the significant 
association with clinical stage T2, higher preope-
rative PSA, higher tumor extent in surgical speci-
men, higher Gleason score in biopsy and surgical 
specimen, and pathological stage >T2. There was 
no significant association with age and positive 
surgical margin. In Yanagisawa’s et al. (17) study, 
Table 2 - Cox proportional hazard analysis of several clinicopathologic factors predicting time to biochemical recurrence 
following radical prostatectomy.
Predictors Hazard ratio (95% CI) Wald test P value
Univariate analysis
Reactive stroma grade 1 1.655 (0.990-2.765) 3.696 0.06
Reactive stroma grade 2 1.320 (0.748-2.329) 0.915 0.34
Reactive stroma grade 3 2.863 (1.386-5.914) 8.071 < 0.01
Preoperative PSA 1.058 (1.036-1.080) 28.700 < 0.01
Biopsy Gleason score 1.293 (0.993-1.684) 3.645 0.06
Biopsy NC 1.126 (1.038-1.221) 8.139 < 0.01
Biopsy %NC 1.012 (1.005-1.019) 10.284 < 0.01
Biopsy mmAC 1.025 (1.007-1.043) 7.721 0.01
Biopsy %mmAC 1.017 (1.008-1.026) 13.306 < 0.01
Multivariate analysis
Model 1
Preoperative PSA 1.042 (1.012-1.073) 7.436 0.01
Biopsy %NC 1.011 (1.001-1.001) 4.288 0.04
Model 2
Preoperative PSA 1.035 (1.003-1.068) 4.522 0.03
Biopsy %mmAC 1.016 (1.003-1.028) 6.216 0.01
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reactive stroma grade in biopsies was significan-
tly associated with clinical and pathological stage, 
surgical margin stage, and Gleason score on biop-
sy. No correlation was found with preoperative 
PSA and age.
The Kaplan-Meier product-limit analysis 
showed that only patients with reactive stroma 
grade 3 had significantly shorter time to bioche-
mical recurrence (Figure-1). In Cox univariate 
analysis reactive stroma grade 3 is a significant 
predictor of shorter time to biochemical recur-
rence (Table-2). Yanagisawa et al. (17) found that 
patients with reactive stroma grade 0 and 3 had 
significantly shorter time to biochemical recur-
rence. A comment on this finding is the fact that 
they included in the same group 15 patients with 
reactive stroma grade 3 and only one patient with 
grade 0 in their series. It is not plausible any in-
fluence of this single patient with reactive stroma 
grade 0 in the analysis.
On multivariate analysis we used two 
models including only variables significantly 
predictive of time to biochemical recurrence on 
univariate analysis (Table-2). In model 1, only 
preoperative PSA and number of needle biopsy 
cores with carcinoma divided by the total number 
of cores (%NC) were significant; in model 2, only 
preoperative PSA and the total length of carcino-
ma in mm in all cores divided by the total length 
of the cores (%mmAC). This result is at odds with 
Yanagisawa’s et al. (17) study on biopsies. Accor-
ding to the authors reactive stroma grade 0 and 
3 was an independent predictor of biochemical 
recurrence by Cox proportional hazard analysis. 
Their analyses were based on 205 patients with 
reactive stroma grade 1 and 2 vs. 16 patients with 
reactive stroma grade 0 and 3 (only one patient 
with grade 0).
In prostate cancer, the reactive stroma sho-
ws myofibroblasts that coexpress smooth-muscle 
marker (α-smooth-muscle actin) and mesenchymal 
marker (vimentin) and loss of late-stage smooth-
-muscle differentiation markers (desmin, calpo-
nin) (18). Based on these histological features, the 
only other study dealing with the prognostic value 
of reactive stroma in prostate carcinoma is Tomas’ 
et al. (18). The authors quantified histochemically 
and immunohistochemically the stromal reaction 
in radical prostatectomies. Patients with a higher 
vimentin or lower desmin expression had a shorter 
disease-free period and on multivariate analysis 
only vimentin expression was a significant pre-
dictor of biochemical recurrence. Further studies 
on needle prostatic biopsies may show utility of 
histochemistry and immunohistochemistry for the 
analysis of  reactive stroma.
CONCLUSIONS
Increasing reactive stroma grade on nee-
dle prostatic biopsies is significantly associated 
with several clinicopathologic adverse findings. 
However, only grade 3 predicts time and risk to 
biochemical recurrence following radical prosta-
tectomy on univariate analysis. On multivariate 
analysis we have not been able to show that reac-
tive stroma grade 3 is an independent predictor of 
biochemical recurrence factoring in preoperative 
PSA and other pathologic findings on biopsy. An 
additional limitation of reactive stroma grade 3 as 
prognostic factor is the relatively rare occurrence 
of this finding (only 5.3% on needle biopsies).
ACKNOWLEDGMENTS
PSA = prostate specific antigen;
SD = standard deviation;
CI = confidence interval;
NC = number of needle biopsy cores with carci-
noma;
%NC = percent of needle biopsy cores with car-
cinoma;
mmAC = total length of cancer in mm in all cores;
%mmAC = percent of total length of cancer in 




1. Rønnov-Jessen L, Petersen OW, Bissell MJ: Cellular changes 
involved in conversion of normal to malignant breast: impor-
tance of the stromal reaction. Physiol Rev. 1996; 76: 69-125.
IBJU | prostate cancer reactive stroma on biopsies
327
2. Martin M, Pujuguet P, Martin F: Role of stromal myofibro-
blasts infiltrating colon cancer in tumor invasion. Pathol Res 
Pract. 1996; 192: 712-7.
3. Dvorak HF: Tumors: wounds that do not heal. Similarities be-
tween tumor stroma generation and wound healing. N Engl J 
Med. 1986; 315: 1650-9.
4. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley 
DR: Reactive stroma in human prostate cancer: induction of 
myofibroblast phenotype and extracellular matrix remodeling. 
Clin Cancer Res. 2002; 8: 2912-23.
5. Cunha GR, Hayward SW, Wang YZ, Ricke WA: Role of the 
stromal microenvironment in carcinogenesis of the prostate. 
Int J Cancer. 2003; 107: 1-10.
6. Zhang Y, Nojima S, Nakayama H, Jin Y, Enza H: Characteris-
tics of normal stromal components and their correlation with 
cancer occurrence in human prostate. Oncol Rep. 2003; 10: 
207-11.
7. Rowley DR: What might a stromal response mean to prostate 
cancer progression? Cancer Metastasis Rev. 1998-1999; 17: 
411-9.
8. De Wever O, Mareel M: Role of tissue stroma in cancer cell 
invasion. J Pathol. 2003; 200: 429-47.
9. Dakhova O, Ozen M, Creighton CJ, Li R, Ayala G, Rowley D, 
et al.: Global gene expression analysis of reactive stroma in 
prostate cancer. Clin Cancer Res. 2009; 15: 3979-89.
10. Niu YN, Xia SJ: Stroma-epithelium crosstalk in prostate can-
cer. Asian J Androl. 2009; 11: 28-35.
11. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, 
Cunha GR: Carcinoma-associated fibroblasts direct tumor 
progression of initiated human prostatic epithelium. Cancer 
Res. 1999; 59: 5002-11.
12. Hayward SW, Cunha GR, Dahiya R: Normal development and 
carcinogenesis of the prostate. A unifying hypothesis. Ann N 
Y Acad Sci. 1996; 784: 50-62.
13. Cunha GR, Hayward SW, Dahiya R, Foster BA: Smooth mus-
cle-epithelial interactions in normal and neoplastic prostatic 
development. Acta Anat (Basel). 1996; 155: 63-72.
14. De Wever O, Mareel M: Role of tissue stroma in cancer cell 
invasion. J Pathol. 2003; 200: 429-47.
15. Tlsty TD: Stromal cells can contribute oncogenic signals. Se-
min Cancer Biol. 2001; 11: 97-104.
16. Ayala G, Tuxhorn JA, Wheeler TM, Frolov A, Scardino PT, Oh-
ori M, et al.: Reactive stroma as a predictor of biochemical-
free recurrence in prostate cancer. Clin Cancer Res. 2003; 9: 
4792-801.
17. Yanagisawa N, Li R, Rowley D, Liu H, Kadmon D, Miles BJ, 
et al.: Stromogenic prostatic carcinoma pattern (carcinomas 
with reactive stromal grade 3) in needle biopsies predicts 
biochemical recurrence-free survival in patients after radical 
prostatectomy. Hum Pathol. 2007; 38: 1611-20.
18. Tomas D, Spajić B, Milosević M, Demirović A, Marusić Z, 
Kruslin B: Intensity of stromal changes predicts biochemical 
recurrence-free survival in prostatic carcinoma. Scand J Urol 
Nephrol. 2010; 44: 284-90.
19. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL; ISUP Grad-
ing Committee: The 2005 International Society of Urological 
Pathology (ISUP) Consensus Conference on Gleason Grading 
of Prostatic Carcinoma. Am J Surg Pathol. 2005; 29: 1228-42.
20. Billis A, Magna LA, Ferreira U: Correlation between tumor ex-
tent in radical prostatectomies and preoperative PSA, histo-
logical grade, surgical margins, and extraprostatic extension: 
application of a new practical method for tumor extent evalua-
tion. Int Braz J Urol. 2003; 29: 113-9; discussion 120.
21. Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D’Amico 
AV, Dmochowski RR, et al.: Variation in the definition of bio-
chemical recurrence in patients treated for localized prostate 
cancer: the American Urological Association Prostate Guide-
lines for Localized Prostate Cancer Update Panel report and 
recommendations for a standard in the reporting of surgical 




Dep. of Anatomic Pathology
School of Medical Sciences 
State University of Campinas (Unicamp)
Rua Tessália Vieira de Camargo, 126
Campinas, SP, 3083-887, Brazil
Fax: + 55 19 3289-3897
E-mail: athanase@fcm.unicamp.br
